$ZS

Rich Michael J. sold $529K of ZS

Rich Michael J. (CRO and President of WW Sales) sold 4,184 shares of Zscaler, Inc. (ZS) at $126.43 ($0.53M total) on 2026-06-16.

Original reporting
SEC EDGAR · Rich Michael J.
Published Jun 18, 2026, 12:07 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 18, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ZS
Neutral
high confidence
Mentioned
$ZS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZSNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings by a senior officer; it does not include any company performance or guidance update.

02

Market read

Traders may monitor insider activity, but this single Form 4 sale without additional catalysts is unlikely to drive sustained repricing.

03

What to watch

Insider sales are often pre-planned for taxes or diversification; the article provides no context on motives, option exercises, or compensation structure.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-17 for a sale executed 2026-06-16

Background

The article is an SEC Form 4 insider transaction disclosure for Zscaler, Inc. (ZS).

Company-level read

Ticker impact

$ZSNeutralHigh confidence
Context

Rich Michael J., Zscaler CRO and President of WW Sales, sold 4,184 shares in an open-market transaction on 2026-06-16.

Expected impact

Likely limited near-term impact; any effect should be small and short-lived unless accompanied by other disclosures.

Evidence & confidence

The filing is an SEC Form 4 insider sale with no 10b5-1 plan and no accompanying company-specific operational or financial catalyst in the text.

Market effects

Minimal; insider sale in a single software name does not materially reset sector expectations from the provided text.

Minimal; no broader regional or macro linkage is provided.

Minimal; the disclosure is company-specific and does not indicate global developments.

Counterpoint

Absence of a 10b5-1 plan could prompt some traders to view the sale as more discretionary, potentially increasing short-term skepticism.

Key entities

  • Zscaler, Inc.

    Issuer of the SEC Form 4 insider transaction; subject of the disclosure.

  • Rich Michael J.

    CRO and President of WW Sales who sold 4,184 shares on 2026-06-16.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ZSMed

Zscaler (ZS) Sets $8B ARR Goal by FY2031 Amid Mixed Analyst View

Zscaler (ZS) aims to reach $8B in annual recurring revenue by FY2031, a 2.4x increase from current revenue. Analysts' views are mixed, with Morgan Stanley lowering its price target to $185 and UBS raising it to $250. The company's P/S ratio is 10.14x, below its historical median of 18.9x, reflecting market skepticism about growth and profitability.

$ZSMed

ZSCALER (ZS) Maintained by JP Morgan -- Price Target Raised to $

JP Morgan maintained an Overweight rating on Zscaler (ZS) and raised its price target from $215 to $245. The company's GF Value™ suggests it is 28.2% undervalued, with a GF Score™ of 76/100. Insider selling totaled $6.4M over the past three months. Zscaler operates in cloud-native cybersecurity, serving large enterprises and government agencies.

$ZSMed

ZS Maintained by Barclays -- Price Target Raised to $225

Barclays maintained an Overweight rating for Zscaler (ZS) and raised its price target to $225 from $220. GuruFocus values ZS at $296.22, suggesting a 29.1% undervaluation at its current price of $210.08. The company has a GF Score of 76/100, indicating strong growth and valuation but low profitability. Insider selling totaled $6.4M in the last 3 months.